Content about INDIANAPOLIS

September 12, 2011

Healthcare giant WellPoint has inked a deal with IBM whereby it will develop applications using IBM's Watson artificial intelligence technology to deliver healthcare information to patients.

INDIANAPOLIS — Healthcare giant WellPoint has inked a deal with IBM whereby it will develop applications using IBM's Watson artificial intelligence technology to deliver healthcare information to patients.

Watson, named for IBM founder Thomas Watson, is a system developed by IBM scientists designed to mimic a human's ability to answer questions posed in natural language that earlier this year appeared on the TV game show "Jeopardy!" and won against two human contestants.

September 12, 2011

A Midwest supermarket retailer will spend $60 million to build up to 10 stores and remodel or rebuild several more over the next three years, according to published reports.

INDIANAPOLIS — A Midwest supermarket retailer will spend $60 million to build up to 10 stores and remodel or rebuild several more over the next three years, according to published reports.

Marsh Supermarkets' new stores will average 40,000 sq. ft. to 60,000 sq. ft., with a strong focus on fresh fruits and vegetables and service-oriented components, according to the Indianapolis Business Journal.

Marsh operates 72 Marsh Supermarkets, 3 O'Malia's Food Markets and 22 MainStreet Market stores in Indiana and Ohio.

September 8, 2011

Boehringer Ingelheim and Eli Lilly will present data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes in Lisbon, Portugal.

RIDGEFIELD, Conn., and INDIANAPOLIS — Boehringer Ingelheim and Eli Lilly will present data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes in Lisbon, Portugal.

September 8, 2011

A few months after launching its multichannel platform to inform and educate patients about healthy eating, physical activity and stress management, drug maker Eli Lilly has debuted a new YouTube channel.

INDIANAPOLIS — A few months after launching its multichannel platform to inform and educate patients about healthy eating, physical activity and stress management, drug maker Eli Lilly has debuted a new YouTube channel.

August 19, 2011

Researchers in Finland said they have confirmed a link between Type 2 diabetes and pesticides known as persistent organic pollutants, according to a new study in the journal Diabetes Care.

INDIANAPOLIS — Researchers in Finland said they have confirmed a link between Type 2 diabetes and pesticides known as persistent organic pollutants, according to a new study in the journal Diabetes Care.

August 16, 2011

A special group of patients who participated in a trial of a heart disease drug made by Daiichi Sankyo and Eli Lilly showed fewer heart attacks, strokes and deaths related to cardiovascular disease than patients taking a competing drug, according to an analysis of study results.

INDIANAPOLIS — A special group of patients who participated in a trial of a heart disease drug made by Daiichi Sankyo and Eli Lilly showed fewer heart attacks, strokes and deaths related to cardiovascular disease than patients taking a competing drug, according to an analysis of study results.

August 11, 2011

CVS Caremark’s MinuteClinic continues to expand its list of strategic alliances, with its latest partner being Indiana University Health (IU Health), the largest health system in Indiana.

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic continues to expand its list of strategic alliances, with its latest partner being Indiana University Health (IU Health), the largest health system in Indiana.

August 1, 2011

A federal court has upheld Eli Lilly's patent covering a drug used to treat attention deficit hyperactivity disorder, Lilly said Friday.

INDIANAPOLIS — A federal court has upheld Eli Lilly's patent covering a drug used to treat attention deficit hyperactivity disorder, Lilly said Friday.

Lilly said the U.S. Court of Appeals for the Federal Circuit overturned a ruling by the U.S. District Court for the District of New Jersey that had invalidated Lilly's patent for Strattera (atomoxetine) in a patent infringement case that Lilly had filed against generic drug maker Actavis, when the latter sought regulatory approval for a generic version of Strattera.

July 28, 2011

AARP magazine last week identified the top 10 retirement destinations, which potentially could be growth opportunities for pharmacy, that offer comfortably affordable lifestyles for seniors.

WASHINGTON — AARP magazine last week identified the top 10 retirement destinations, which potentially could be growth opportunities for pharmacy, that offer comfortably affordable lifestyles for seniors.

July 27, 2011

Eli Lilly has launched its physician payment registry, a website that enables visitors to search payments to individual U.S.-based physicians and the institutions or research organizations that receive payments on behalf of a physician.

INDIANAPOLIS — Eli Lilly has launched its physician payment registry, a website that enables visitors to search payments to individual U.S.-based physicians and the institutions or research organizations that receive payments on behalf of a physician.

The drug maker said that its website, which is in line with its corporate integrity agreement with the U.S. government, aims to show how the company works with U.S. physicians and compensates them for their services and how these collaborations benefit patient care.

July 18, 2011

The Department of Health and Human Services on Friday announced the winners of an awards program that highlights innovative health promotion projects that have demonstrated a significant impact on the health of the community within the past three years.

WASHINGTON — The Department of Health and Human Services on Friday announced the winners of an awards program that highlights innovative health promotion projects that have demonstrated a significant impact on the health of the community within the past three years.

July 18, 2011

A statin made by Eli Lilly and Kowa Pharmaceuticals America appears to work well with drugs used to treat HIV, according to a study presented at the sixth International AIDS Society conference on HIV Pathogenesis, Treatment and Prevention in Rome.

INDIANAPOLIS — A statin made by Eli Lilly and Kowa Pharmaceuticals America appears to work well with drugs used to treat HIV, according to a study presented at the sixth International AIDS Society conference on HIV Pathogenesis, Treatment and Prevention in Rome.

The study was designed to investigate potential interactions between Livalo (pitavastatin) and Abbott’s antiretroviral protease inhibitor Kaletra (lopinavir and ritonavir). The study found that each drug had only a minimal effect on the other.

July 14, 2011

Eli Lilly & Co. and Disney are collaborating to produce a dedicated lifestyle website and publications for families affected by Type 1 diabetes, the two companies said Thursday.

INDIANAPOLIS — Eli Lilly & Co. and Disney are collaborating to produce a dedicated lifestyle website and publications for families affected by Type 1 diabetes, the two companies said Thursday.

July 5, 2011

Eli Lilly's SVP global quality has joined the drug maker's executive committee, effective July 1.

INDIANAPOLIS — Eli Lilly's SVP global quality has joined the drug maker's executive committee, effective July 1.

Fionnuala Walsh, who joined Lilly in 1988, will continue in her current role at Lilly, where she ensures the company maintains high-quality standards across its worldwide operations.

Walsh reports to company chairman, president and CEO John Lechleiter.

June 30, 2011

Marsh Supermarkets has created a new executive position that will focus on merchandising support, including pricing, space management, corporate brands and business intelligence.

INDIANAPOLIS — Marsh Supermarkets has created a new executive position that will focus on merchandising support, including pricing, space management, corporate brands and business intelligence.

The retailer said that retail veteran David Siegel will be Marsh's SVP merchandising and marketing strategic initiatives.

Siegel joins the company from Schenectady, N.Y.-based Price Chopper.

Marsh operates 72 Marsh Supermarkets, 3 O'Malia's Food Markets and 22 MainStreet Market stores in Indiana and Ohio.

June 29, 2011

A topical drug made by Eli Lilly restored testosterone to normal levels in men with abnormally low testosterone, according to results of a late-stage clinical trial.

INDIANAPOLIS — A topical drug made by Eli Lilly restored testosterone to normal levels in men with abnormally low testosterone, according to results of a late-stage clinical trial.

Lilly announced results of a phase-3 trial of Axiron (testosterone) topical solution, a treatment for the condition, also known as hypogonadism. Study results also showed that the drug improved symptoms associated with it.

Hypogonadism results from damage or disease of the testicles, hypothalamus or pituitary glands that inhibits production of testosterone.

June 23, 2011

Locating retail health clinics and urgent care centers just got easier for patients seeking nonemergency care when their regular doctors are not available, thanks to an emergency room program and education campaign that incorporates Google Maps launched by WellPoint's affiliated health plans.

INDIANAPOLIS — Locating retail health clinics and urgent care centers just got easier for patients seeking nonemergency care when their regular doctors are not available, thanks to an emergency room program and education campaign that incorporates Google Maps launched by WellPoint's affiliated health plans.

June 20, 2011

Last month, the Food and Drug Administration approved Tradjenta (linagliptin), an oral Type 2 diabetes drug made by German drug maker Boehringer Ingelheim and Indianapolis-based Eli Lilly. The drug belongs to the class known as dipeptidyl peptidase-4 inhibitors, which also includes Merck’s Januvia (sitagliptin). With diabetes affecting some 26 million Americans and growing rapidly, Drug Store News spoke with Wa’el Hashad, BI’s VP cardiovascular and metabolic disorders marketing, about what the approval of Tradjenta means for the diabetes market.


June 15, 2011

A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.

INDIANAPOLIS — A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.

Lilly and BI announced the availability of Tradjenta (linagliptin) in chain and independent pharmacies around the country.

June 14, 2011

Drug maker Eli Lilly has created a multichannel platform to inform and educate patients about healthy eating, physical activity and stress management.

INDIANAPOLIS — Drug maker Eli Lilly has created a multichannel platform to inform and educate patients about healthy eating, physical activity and stress management.

The program, Lilly for Better Health, is designed to help users live healthier, more active lives, and Lilly said it was designed to reach patients where they like to receive health information. The program includes a website, LillyForBetterHealth.com.

June 9, 2011

A federal court has ruled in favor of drug maker Eli Lilly & Co. in a dispute with Amylin Pharmaceuticals over Lilly’s partnership with German drug maker Boehringer Ingelheim.

INDIANAPOLIS — A federal court has ruled in favor of drug maker Eli Lilly in a dispute with Amylin Pharmaceuticals over Lilly’s partnership with German drug maker Boehringer Ingelheim.

June 9, 2011

Patients with Type 1 diabetes using an insulin product made by Eli Lilly can store it in their pumps for longer periods of time, while children using it have additional options, thanks to a labeling change approved Wednesday by the Food and Drug Administration.

INDIANAPOLIS — Patients with Type 1 diabetes using an insulin product made by Eli Lilly can store it in their pumps for longer periods of time, while children using it have additional options, thanks to a labeling change approved Wednesday by the Food and Drug Administration.

June 6, 2011

Cancer patients taking a drug made by Eli Lilly extended the amount of time they survived without their disease worsening, according to results of a study announced Sunday.

INDIANAPOLIS — Cancer patients taking a drug made by Eli Lilly extended the amount of time they survived without their disease worsening, according to results of a study announced Sunday.

Lilly said results of the phase-3 “PARAMOUNT” study of the injected drug Alimta (pemetrexed) extended progression-free survival in patients with nonsquamous nonsmall-cell lung cancer. The study focused on continuation maintenance when one of the same drugs used as a first-line treatment for cancer is continued as maintenance therapy in an effort to control the disease.

May 24, 2011

Drug maker Eli Lilly is partnering with two private investor groups to form a new biotech company based in central Indiana, the company said Monday.

INDIANAPOLIS — Drug maker Eli Lilly is partnering with two private investor groups to form a new biotech company based in central Indiana, the company said Monday.

Lilly signed a deal with Care Capital and NovaQuest Capital to establish BioCritica, a privately held biotechnology company that will focus on continued U.S. development and commercialization of the severe sepsis treatment Xigris (drotrecogin alfa [activated]). The new company also will expand its portfolio of critical care medicines for hospitals.

May 23, 2011

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


SUPPLIER NEWS — The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.